We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ascendis Pharma and Novo Nordisk Sign Collaboration for Development and Commercialization of TransCon Technology-based Products in Metabolic and Cardiovascular Diseases - Collaboration leverages...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2 | -1.65289256198 | 121 | 121 | 113 | 24 | 119.0625 | DE |
4 | 7 | 6.25 | 112 | 121 | 112 | 100 | 117.54570136 | DE |
12 | -4 | -3.25203252033 | 123 | 135 | 97 | 73 | 120.0881472 | DE |
26 | -3 | -2.45901639344 | 122 | 135 | 97 | 59 | 121.27263213 | DE |
52 | -13 | -9.84848484848 | 132 | 143 | 97 | 57 | 124.1737811 | DE |
156 | -13 | -9.84848484848 | 132 | 143 | 97 | 57 | 124.1737811 | DE |
260 | -13 | -9.84848484848 | 132 | 143 | 97 | 57 | 124.1737811 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions